Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biotechnology Business
Statement by InterMune, Inc. Regarding Justice Department Action Against Former Employee for Past Conduct
April 5th, 2008
InterMune, Inc. (NASDAQ:ITMN) issued the following statement regarding today's indictment of a former employee in connection with the promotional activities for Actimmune(R) (interferon gamma-1b) during a period that ended in June of 2003. "Today's indictment concerns conduct by a former employee who left the company more than four years ago. "In 2006, InterMune settled all government claims related to that conduct, without criminal sanctions against the company. At the time, the government acknowledged that InterMune fully cooperated with its investigation and had instituted numerous and comprehensive compliance changes before the investigation even...
Source: Law & Health Weekly (2008-04-05)
|
